We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-0.77%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.55B
AUM Growth
-$472M
Cap. Flow
-$301M
Cap. Flow %
-3.99%
Top 10 Hldgs %
20.77%
Holding
863
New
59
Increased
344
Reduced
256
Closed
128

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$25.4M
2
ABBV icon
AbbVie
ABBV
+$21.9M
3
KYNB
Kyntra Bio
KYNB
+$19.2M
4
WM icon
Waste Management
WM
+$19M
5
GILD icon
Gilead Sciences
GILD
+$17.7M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$70.2M
2
ARRY
Array Biopharma Inc
ARRY
+$45.8M
3
BIIB icon
Biogen
BIIB
+$43.3M
4
META icon
Meta Platforms (Facebook)
META
+$24.8M
5
AMGN icon
Amgen
AMGN
+$21.7M

Sector Composition

Rank Sector Weight
1 Healthcare 31.81%
2 Technology 18.27%
3 Financials 10.05%
4 Consumer Discretionary 9.39%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITCI
251
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6.86M 0.09%
918,000
+400,000
+77% +$3.84M
DD icon
252
DuPont de Nemours
DD
$18.8B
$6.82M 0.09%
76,196
-4,510
-6% -$397K
MCK icon
253
McKesson
MCK
$100B
$6.81M 0.09%
49,817
+36,142
+264% +$5.13M
EW icon
254
Edwards Lifesciences
EW
$47.9B
$6.74M 0.09%
92,007
+18,720
+26% +$1.32M
VMW
255
DELISTED
VMware, Inc
VMW
$6.67M 0.09%
44,456
+2,007
+5% +$316K
MAS icon
256
Masco
MAS
$16.2B
$6.67M 0.09%
159,968
-13,626
-8% -$546K
RGA icon
257
Reinsurance Group of America
RGA
$15.7B
$6.55M 0.09%
40,968
-1,251
-3% -$194K
HST icon
258
Host Hotels & Resorts
HST
$17B
$6.54M 0.09%
378,350
+35,654
+10% +$609K
IMMU
259
DELISTED
Immunomedics Inc
IMMU
$6.49M 0.09%
489,300
-241,100
-33% -$3.54M
LNG icon
260
Cheniere Energy
LNG
$54.1B
$6.46M 0.09%
102,489
+16,378
+19% +$1.05M
GPRK icon
261
GeoPark
GPRK
$618M
$6.41M 0.08%
+349,392
New +$6.24M
CCI icon
262
Crown Castle
CCI
$32.4B
$6.39M 0.08%
45,970
-1,023
-2% -$141K
TCDA
263
DELISTED
Tricida, Inc. Common Stock
TCDA
$6.3M 0.08%
204,000
+180,899
+783% +$6.06M
PGR icon
264
Progressive
PGR
$125B
$6.19M 0.08%
80,074
+3,834
+5% +$302K
CME icon
265
CME Group
CME
$92.1B
$6.16M 0.08%
29,166
+2,452
+9% +$512K
EIX icon
266
Edison International
EIX
$30.4B
$6.05M 0.08%
80,227
+24,356
+44% +$1.75M
DVN icon
267
Devon Energy
DVN
$50.1B
$6.02M 0.08%
250,208
+11,906
+5% +$298K
RARE icon
268
Ultragenyx Pharmaceutical
RARE
$2.66B
$6.01M 0.08%
140,500
+15,000
+12% +$815K
BA icon
269
Boeing
BA
$168B
$6.01M 0.08%
15,794
-9,586
-38% -$3.43M
AME icon
270
Ametek
AME
$55.3B
$5.95M 0.08%
64,803
-53,756
-45% -$4.74M
PNC icon
271
PNC Financial Services
PNC
$99.5B
$5.94M 0.08%
42,354
+2,455
+6% +$333K
UNM icon
272
Unum
UNM
$13.8B
$5.93M 0.08%
199,576
+446
+0.2% +$13.2K
ECL icon
273
Ecolab
ECL
$76.6B
$5.9M 0.08%
29,781
+2,278
+8% +$457K
GWPH
274
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$5.89M 0.08%
51,200
– –
AFYA icon
275
Afya
AFYA
$1.3B
$5.82M 0.08%
+227,000
New +$5.86M
9 10
11
12 13

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2019 Portfolio in Review

As of Q3 2019, Candriam SCA held 863 positions worth $7.55B, down 5.9% from $8.02B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA withdrew a net $301M in Q3 2019, closing 128 positions and reducing 256 holdings. Its most notable exit was Celgene Corp, an estimated $70.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Nike worth $27.8M.

  • Candriam SCA's largest Q3 2019 buy was Nike: 295,763 shares worth $27.8M.
  • Candriam SCA added most to AbbVie in Q3 2019, an estimated $21.9M increase.
  • Candriam SCA's biggest Q3 2019 reduction was Biogen, cutting an estimated $43.3M.
  • Candriam SCA fully exited Celgene Corp in Q3 2019, selling an estimated $70.2M.
  • Candriam SCA's ten largest holdings make up 21% of its $7.55B portfolio in Q3 2019.
  • Candriam SCA opened 59 new positions and closed 128 in Q3 2019.
  • Candriam SCA's portfolio value fell 5.9% quarter-over-quarter to $7.55B.

Based on Candriam SCA's 13F filing for Q3 2019, filed 21 Oct 2019.